Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was planned to examine the effects of Pilates training in patients with drug-resistant epilepsy. It was planned to include 40 epilepsy patients in the study. The control group was planned to continue routine drug treatment for 8 weeks. The Pilates group was planned to receive Pilates training 3 days a week for 8 weeks in addition to routine drug treatment. It was aimed to examine the effects of Pilates training performed 3 times a week for 8 weeks on seizure frequency, core stability, balance, functional exercise capacity, cognitive functions, dual task, fatigue, kinesiophobia, sleep quality, depression and quality of life in patients with drug-resistant epilepsy.
This study was planned to investigate the effects of Pilates training, a "core" stability-based exercise method that improves body alignment, postural control, and balance in patients with drug-resistant epilepsy, on seizure frequency, core stability, balance, functional exercise capacity, cognitive functions, dual task, fatigue, kinesiophobia, sleep quality, depression, and quality of life. It was planned to include 40 epilepsy patients in the study. The patients were planned to be randomly divided into two groups as Pilates (n: 20) and control (n: 20). The control group was planned to continue routine drug treatment for 8 weeks. The Pilates group was planned to receive Pilates training 3 days a week for 8 weeks in addition to routine drug treatment. Seizure frequency with the seizure diary; the "core" power with the "sit-ups" and the modified "push-ups" tests; the "core" endurans with the lateral bridge, the trunk flexor endurance, the prone bridge and the modified "Biering-Sorensen" tests; balance with the Balance Error Scoring System (BESS) and the Four-Step Square Test (FSTT); functional exercise capacity with the 6-Minute Walk Test (6-MWT); functional mobility and dual task with the Timed Up and Go Test (TUG); cognitive functions with the BILNOT battery; fatigue with the Fatigue Severity Scale (FSS); kinesiophobia with the Tampa Kinesiophobia Scale; sleep quality with the Pittsburgh Sleep Quality Index (PSQI); depression with the Neurological Disorders Depression Inventory in Epilepsy (NDDI); and health-related quality of life with the Quality of Life in Epilepsy Scale (QOLIE-31) were evaluated before and after treatment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pilates Group | Experimental | Pilates training will be given individually for approximately 1 hour, 3 days a week for 8 weeks. |
|
| Control Group | Active Comparator | Routine medication will be continued for 8 weeks. |
|
| Evaluation of seizure frequency | No Intervention | Seizure frequency will be calculated based on the patient's diary in the 2 months prior to the assessment. Patients without a seizure diary will be given one and asked to record their seizures for 2 months. | |
| Evaluation of core stability | No Intervention | "Core" stability was evaluated with two important dimensions, "core" strength and endurance tests. | |
| Evaluation of balance | No Intervention | Balance will be assessed separately with static and dynamic balance tests. The Balance Error Scoring System test will be used to assess static balance, and the Four-Step Square Test will be used to assess dynamic balance. | |
| Evaluation of Functional Exercise Capacity |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pilates Group | Other | Pilates training will be given individually for approximately 1 hour, 3 days a week for 8 weeks. Before starting the exercise training, all participants will be taught the basic elements of Pilates in 1 session. Pilates training will begin with standing exercises for warming up and centering in the supine position. Training will continue with upper and lower extremity movements. The intensity of the exercises will be increased by using different positions and elastic bands. Stretching exercises and posture exercises will be used during the cool-down period. All exercises will start with 10 repetitions and will be increased to 20 later. Each movement will be shown by the physiotherapist first so that the patients can do the movements correctly. The movements that the patients cannot do will be modified appropriately and applied. |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of Physical Activity Level | Physical activity level will be assessed with the long form of the International Physical Activity Questionnaire (IPAQ). | 8 week |
| Evaluation of Seizure Frequency | Seizure frequency will be calculated based on the patient's seizure diary for the 2 months prior to the assessment. Patients without a seizure diary will be given a seizure diary and asked to record their seizures for 2 months. | 8 week |
| Evaluation of the Strength of "Core" Muscles | Core muscle strength will be assessed with sit-ups and modified push-ups. The number of times individuals can perform each test for 30 seconds will be recorded. Each measurement will be made twice and the best measurement will be used in statistical analysis. | 8 week |
| Evaluation of the Endurance of "Core" Muscles | Static endurance of the core muscles will be assessed using the McGill protocol using the lateral bridge test, the Modified Biering-Sorensen trunk extension test, the trunk flexor endurance test, and the prone bridge test. The time that individuals can maintain the test position will be recorded in seconds using a stopwatch. Each measurement will be made twice and the best measurement will be used in the statistical analysis. The test will be terminated when individuals break the test position or say that they cannot continue the test. | 8 week |
| Evaluation of Balance | Balance will be assessed separately with static and dynamic balance tests. The Balance Error Scoring System test will be used to assess static balance, and the Four-Step Square Test will be used to assess dynamic balance. | 8 week |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Derya CAGLAR, PhD candidate | Recep Tayyip Erdogan University Vocational School of Physical Therapy and Rehabilitation | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Recep Tayyip Erdogan University Vocational School of Physical Therapy and Rehabilitation | Rize | Güneysu | 53350 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004827 | Epilepsy |
| D060825 | Cognitive Dysfunction |
| D012640 | Seizures |
| D003863 | Depression |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D003072 | Cognition Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D035061 | Control Groups |
| ID | Term |
|---|---|
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D012107 | Research Design |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Functional exercise capacity was evaluated using the 6 Minute Walking Test (6-MWT). |
| Evaluation of cognitive function | No Intervention | Cognitive function will be assessed with the Standardized Mini Mental State Examination and the Neuropsychological Test Battery for Cognitive Potentials. |
| Evaluation of dual task | No Intervention | Dual task will be evaluated by adding a second task to the Timed Up and Go Test (TUG). |
| Evaluation of fatigue | No Intervention | Fatigue will be assessed using the Fatigue Severity Scale (FSS). |
| Evaluation of kinesiophobia | No Intervention | Kinesiophobia will be assessed with the Tampa Kinesiophobia Scale (TKS). |
| Evaluation of sleep quality | No Intervention | Sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI). |
| Evaluation of depression | No Intervention | The Inventory of Neurological Disorders Depression in Epilepsy will be used to assess depression. |
| Evaluation of quality of life | No Intervention | Quality of Life In Epilepsy (QOLIE-31) will be used to determine health-related quality of life in epilepsy. |
|
| Control Group | Other | No exercise will be allowed for 8 weeks and routine medication will continue. |
|
| Evaluation of Functional Exercise Capacity |
Functional exercise capacity will be assessed with the 6-Minute Walk Test (6-MWT) in accordance with the American Thoracic Society criteria. |
| 8 week |
| Evaluation of Cognitive Function | Cognitive function will be assessed with the Standardized Mini Mental Test and the Neuropsychological Test Battery for Cognitive Potentials. | 8 week |
| Evaluation of Dual Task | Dual task will be evaluated by adding a second task to the Timed Up and Go Test. For the motor task, individuals will be asked to carry an empty tray. For the cognitive task, they will be asked to count backwards from 100 by 7s (mental tracking) and to count words starting with the letter A (verbal fluency). The time will be recorded with a stopwatch. The test will be done twice, one as a trial, and the final measurement will be used in statistical analysis. | 8 week |
| Evaluation of Fatigue | Fatigue will be assessed using the Fatigue Severity Scale. | 8 week |
| Evaluation of Kinesiophobia | Kinesiophobia will be assessed using the Tampa Kinesiophobia Scale. | 8 week |
| Evaluation of Sleep Quality | Sleep quality will be assessed using the Pittsburgh Sleep Quality Index. | 8 week |
| Evaluation of Depression | The Inventory of Neurological Disorders Depression in Epilepsy will be used to assess depression. | 8 week |
| Evaluation of Quality of Life | The Epilepsy Quality of Life Scale will be used to determine health-related quality of life in epilepsy. | 8 week |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D008722 | Methods |